These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 8246147

  • 21. Bacterial neurotoxins--a thousand years later.
    Linial M.
    Isr J Med Sci; 1995 Oct; 31(10):591-5. PubMed ID: 7591680
    [Abstract] [Full Text] [Related]

  • 22. [Tetanus and botulinum toxins are zinc metallopeptidases: molecular mechanisms and inhibition of their neurotoxicity].
    Cornille F, Roques BP.
    J Soc Biol; 1999 Oct; 193(6):509-16. PubMed ID: 10783709
    [Abstract] [Full Text] [Related]

  • 23. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S, Bartoszcze M, Gryko R.
    Przegl Epidemiol; 2007 Oct; 61(3):519-27. PubMed ID: 18069389
    [Abstract] [Full Text] [Related]

  • 24. Central effects of tetanus and botulinum neurotoxins.
    Caleo M, Schiavo G.
    Toxicon; 2009 Oct; 54(5):593-9. PubMed ID: 19264088
    [Abstract] [Full Text] [Related]

  • 25. Functional characterisation of tetanus and botulinum neurotoxins binding domains.
    Lalli G, Herreros J, Osborne SL, Montecucco C, Rossetto O, Schiavo G.
    J Cell Sci; 1999 Aug; 112 ( Pt 16)():2715-24. PubMed ID: 10413679
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic experiments on the interaction between crotoxin and the mammalian neuromuscular junction.
    Trivedi S, Kaiser II, Tanaka M, Simpson LL.
    J Pharmacol Exp Ther; 1989 Nov; 251(2):490-6. PubMed ID: 2553923
    [Abstract] [Full Text] [Related]

  • 27. The study of clostridial and related toxins. The search for unique mechanisms and common denominators.
    Simpson LL.
    J Physiol (Paris); 1990 Nov; 84(2):143-51. PubMed ID: 2290129
    [Abstract] [Full Text] [Related]

  • 28. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA, Bakry NM, Maksymowych AB, Simpson LL.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
    [Abstract] [Full Text] [Related]

  • 29. Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments.
    Joshi SG, Elias M, Singh A, Al-Saleem FH, Ancharski D, Nasser Z, Takahashi T, Simpson LL.
    Neuroscience; 2011 Apr 14; 179():208-22. PubMed ID: 21277940
    [Abstract] [Full Text] [Related]

  • 30. Ethyl acetate extract from black tea prevents neuromuscular blockade by botulinum neurotoxin type A in vitro.
    Satoh E.
    Int J Food Sci Nutr; 2005 Dec 14; 56(8):543-50. PubMed ID: 16638658
    [Abstract] [Full Text] [Related]

  • 31. Neuropharmacological characterization of fragment B from tetanus toxin.
    Simpson LL, Hoch DH.
    J Pharmacol Exp Ther; 1985 Jan 14; 232(1):223-7. PubMed ID: 3965693
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
    Sellin LC, Kauffman JA, Dasgupta BR.
    Med Biol; 1983 Apr 14; 61(2):120-5. PubMed ID: 6308364
    [Abstract] [Full Text] [Related]

  • 33. Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease.
    de Paiva A, Ashton AC, Foran P, Schiavo G, Montecucco C, Dolly JO.
    J Neurochem; 1993 Dec 14; 61(6):2338-41. PubMed ID: 8245989
    [Abstract] [Full Text] [Related]

  • 34. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.
    Schiavo G, Rossetto O, Montecucco C.
    Semin Cell Biol; 1994 Aug 14; 5(4):221-9. PubMed ID: 7994006
    [Abstract] [Full Text] [Related]

  • 35. The role of zinc binding in the biological activity of botulinum toxin.
    Simpson LL, Maksymowych AB, Hao S.
    J Biol Chem; 2001 Jul 20; 276(29):27034-41. PubMed ID: 11358966
    [Abstract] [Full Text] [Related]

  • 36. Comparison of extracellular and intracellular potency of botulinum neurotoxins.
    Cai F, Adrion CB, Keller JE.
    Infect Immun; 2006 Oct 20; 74(10):5617-24. PubMed ID: 16988237
    [Abstract] [Full Text] [Related]

  • 37. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL.
    Infect Immun; 1986 Jun 20; 52(3):858-62. PubMed ID: 3011675
    [Abstract] [Full Text] [Related]

  • 38. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR, Marvaud JC, Raffestin S.
    Ann Pharm Fr; 2001 May 20; 59(3):176-90. PubMed ID: 11427819
    [Abstract] [Full Text] [Related]

  • 39. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.
    Foran P, Shone CC, Dolly JO.
    Biochemistry; 1994 Dec 27; 33(51):15365-74. PubMed ID: 7803399
    [Abstract] [Full Text] [Related]

  • 40. Molecular pharmacology of botulinum toxin and tetanus toxin.
    Simpson LL.
    Annu Rev Pharmacol Toxicol; 1986 Dec 27; 26():427-53. PubMed ID: 3521461
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.